AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Profound Medical Corp. Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG0076T0BS9
5.56▼ 0.20 (-3.47%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
5.76
Day's Range
5.54 – 5.79
52-Week Range
4.80 – 8.95
Volume
135.9K
Avg Volume
252.5K
Share Statistics
Shares Outstanding
Employees
162
Exchange
XNAS
Listed
2016-05-09
Share count as of August 6, 2026

Profound Medical Corp. Common Stock (PROF) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Profound Medical Corp. Common Stock (PROF)
What is Profound Medical Corp. Common Stock's Market Cap?
Profound Medical Corp. Common Stock's Market Cap is $203.1M, based on as-reported figures from SEC (XBRL) filings.
What is Profound Medical Corp. Common Stock's Enterprise Value?
Profound Medical Corp. Common Stock's Enterprise Value is $169.4M, based on as-reported figures from SEC (XBRL) filings.
What is Profound Medical Corp. Common Stock's Price / Sales?
Profound Medical Corp. Common Stock's Price / Sales is 10.6×, based on as-reported figures from SEC (XBRL) filings.
What is Profound Medical Corp. Common Stock's EV / Revenue?
Profound Medical Corp. Common Stock's EV / Revenue is 8.9×, based on as-reported figures from SEC (XBRL) filings.
What is Profound Medical Corp. Common Stock's EV / EBITDA?
Profound Medical Corp. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Profound Medical Corp. Common Stock's Revenue (TTM)?
Profound Medical Corp. Common Stock's Revenue (TTM) is $19.1M, based on as-reported figures from SEC (XBRL) filings.
What is Profound Medical Corp. Common Stock's Net Income (TTM)?
Profound Medical Corp. Common Stock's Net Income (TTM) is -$32.7M, based on as-reported figures from SEC (XBRL) filings.
What is Profound Medical Corp. Common Stock's EBITDA?
Profound Medical Corp. Common Stock's EBITDA is -$34.9M, based on as-reported figures from SEC (XBRL) filings.
What is Profound Medical Corp. Common Stock's Diluted EPS (TTM)?
Profound Medical Corp. Common Stock's Diluted EPS (TTM) is -0.90, based on as-reported figures from SEC (XBRL) filings.
What is Profound Medical Corp. Common Stock's EBITDA Margin?
Profound Medical Corp. Common Stock's EBITDA Margin is -182.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PROFAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
Revenue (note 12)
YoY growth+12.3%+103.6%+43.1%+86.8%
Cost of sales
Gross profit
% of revenue78.4%71.8%66.8%74.3%
Operating expenses
Research and development
Selling, general and administrative
Total operating expenses
% of revenue524.1%222.1%190.1%242.8%
Operating loss
% of revenue445.7%150.3%123.3%168.5%
Other (income) expenses
Net finance income
Net foreign exchange (gain) loss
Total other (income) expenses
Net loss before income taxes
Net loss attributed to shareholders for the period
% of revenue384.2%132.2%136.8%150.8%
Basic net loss per common share (in dollars per share)
Diluted net loss per common share (in dollars per share)